Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions

MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions

US Patent 11465994 · Granted Oct 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Orexin 1 receptor antagonists2025
Oxexin 1 receptor antagonists2025
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2024
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2022
Pyrazole derivatives as bromodomain inhibitors2021
Piperidine derivatives for use in the treatment or prevention of psychiatric and2020
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2020
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2019
1-sulfonyl piperidine derivatives as modulators of prokineticin receptors2019
1-sulfonyl piperidine derivatives as modulators of prokineticin receptors2019
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated2019
Piperidine and azepine derivatives as prokineticin receptor modulators2018